Study guide

Eclampsia, HELLP and antepartum bleeding

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Eclampsia, HELLP and antepartum bleeding

Key Takeaways Explain This Topic AI

Magnesium sulfate treats eclampsia and requires toxicity monitoring.

Stop magnesium and seek urgent treatment if toxicity develops.

Placental abruption severity is not reliably measured by visible vaginal blood loss.

Last updated: October 2026

Eclampsia and Seizure Management

Eclampsia is defined as the occurrence of generalized tonic-clonic convulsions in a woman with pre-eclampsia, which cannot be attributed to other neurological pathology (e.g., epilepsy, intracranial haemorrhage, encephalitis).

Emergency Resuscitation and Anticonvulsant Protocol

During an eclamptic seizure: Protect from injury, position safely, call for help and support oxygenation/airway as needed. Never insert a bite guard, fingers or any object into the mouth. Give magnesium under the emergency protocol and treat severe blood pressure.

First-Line Anticonvulsant — Magnesium Sulfate ( M g S O 4 MgSO_4 M g S O 4 ​ ) :

Loading Dose : 4 g 4\text{ g} 4 g IV diluted in 0.9% sodium chloride, infused slowly over 15 to 20 minutes.

Maintenance Infusion : Continuous intravenous infusion of 1 g/hour 1\text{ g/hour} 1 g/hour for at least 24 hours following delivery or the last seizure.

Recurrent Seizure during Infusion : Administer an additional IV bolus of 2 g 2\text{ g} 2 g M g S O 4 MgSO_4 M g S O 4 ​ over 5 minutes.

Clinical Monitoring for Magnesium Toxicity :

Patellar (Deep Tendon) Reflexes : Checked hourly; must remain present.

Respiratory Rate : Checked hourly; must remain ≥ 12 breaths/min \ge 12\text{ breaths/min} ≥ 12 breaths/min .

Urine Output : Measured hourly via indwelling Foley catheter; must exceed ≥ 25 – 30 mL/hour \ge 25\text{–}30\text{ mL/hour} ≥ 25 – 30 mL/hour because magnesium is eliminated exclusively by the kidneys.

Therapeutic Serum Magnesium Range : 2.0 to 3.5 mmol/L 2.0\text{ to }3.5\text{ mmol/L} 2.0 to 3.5 mmol/L .

Toxicity Progression : Loss of patellar reflexes occurs at 3.5 – 5.0 mmol/L 3.5\text{–}5.0\text{ mmol/L} 3.5 – 5.0 mmol/L ; respiratory depression develops at 5.0 – 6.5 mmol/L 5.0\text{–}6.5\text{ mmol/L} 5.0 – 6.5 mmol/L ; and cardiac conduction blocks / asystole occur at > 7.5 mmol/L > 7.5\text{ mmol/L} > 7.5 mmol/L .

Magnesium Antidote : If toxicity is suspected (absent reflexes or respiratory rate < 12 < 12 < 12 ), cease the infusion immediately and administer intravenous calcium gluconate 10% ( 10 mL 10\text{ mL} 10 mL [1 g]) slowly over 3 to 5 minutes.

Abruption: Stabilise the mother and assess fetal status, bleeding and coagulopathy. Delivery route depends on urgency, fetal compromise and whether vaginal birth is imminent. Not every abruption with a live fetus requires immediate caesarean delivery. Normal ultrasound does not exclude abruption.

HELLP Syndrome

HELLP syndrome is a severe variant of pre-eclampsia characterized by endothelial injury, microvascular thrombi, and hepatic sinusoid obstruction:

H (Haemolysis) : Microangiopathic haemolytic anaemia demonstrated by fragmented red blood cells (schistocytes, burr cells) on blood film, elevated serum lactate dehydrogenase (LDH) > 600 U/L > 600\text{ U/L} > 600 U/L , unconjugated hyperbilirubinaemia, and low serum haptoglobin.

EL (Elevated Liver Enzymes) : Serum transaminases ( ALT or AST ≥ 70 U/L \ge 70\text{ U/L} ≥ 70 U/L or > 2 × > 2 \times > 2 × upper limit of normal).

LP (Low Platelets) : Thrombocytopenia with platelet count < 100 × 10 9 /L < 100 \times 10^9\text{/L} < 100 × 1 0 9 /L .

Antepartum Haemorrhage (APH)

Antepartum haemorrhage is defined as genital tract bleeding occurring from 20 + 0 20^{+0} 2 0 + 0 weeks gestation until the birth of the baby. The two most critical causes are placenta praevia and placental abruption.

Placenta Praevia

Placental location: Placenta praevia overlies the internal os; a placental edge within 20 mm but not covering it is low lying. Transvaginal ultrasound is safe and clarifies location. Avoid digital vaginal examination until praevia has been excluded.

Risk Factors : Previous caesarean section (risk escalates dramatically with each additional caesarean), multiparity, advanced maternal age, prior uterine curettage, multiple pregnancy, and smoking.

Clinical Presentation : Recurrent episodes of painless, bright red vaginal bleeding occurring spontaneously without provocative trauma or contractions. On abdominal examination, the uterus is soft, non-tender, and relaxed , and the fetal lie is frequently abnormal (transverse, oblique, or high floating breech). The fetal heart rate and cardiotocography (CTG) are typically normal and reassuring.

The Cardinal Rule : NEVER perform a digital vaginal examination in any woman presenting with antepartum haemorrhage until placenta praevia has been definitively excluded by ultrasound. Digital disruption of low-lying placental cotyledons or cervical vessels can provoke sudden, life-threatening exsanguination.

Diagnosis and Management : Transvaginal ultrasonography (TVS) is safe and superior to transabdominal scanning for assessing the relationship of the placental edge to the internal os. Management involves hospital admission, large-bore IV access, crossmatching 2 to 4 units of packed red blood cells, administration of anti-D if Rh-negative, and planned elective caesarean section at 36 + 0 to 37 + 6 36^{+0}\text{ to }37^{+6} 3 6 + 0 to 3 7 + 6 weeks (or emergent delivery if massive unremitting haemorrhage ensues).

Placental Abruption (Abruptio Placentae)

Definition : Premature separation of a normally located placenta from the decidua basalis prior to delivery of the fetus.

Risk Factors : Maternal chronic hypertension or pre-eclampsia (strongest risk factor), blunt abdominal trauma (motor vehicle collision, domestic violence), illicit substance abuse (cocaine, amphetamines), cigarette smoking, sudden uterine decompression (rupture of membranes in polyhydramnios or delivery of first twin), and prior abruption.

Clinical Presentation : Painful, dark red vaginal bleeding accompanied by continuous, severe abdominal or lower back pain. On physical examination, the uterus is hypertonic, tense, rigid ("woody"), and exquisitely tender to palpation. Signs of maternal hypovolaemic shock (tachycardia, hypotension, pallor) are frequently out of proportion to visible vaginal blood loss because a substantial proportion of bleeding may be concealed retroplacentally (in ~20% of cases).

Fetal and Coagulation Status : Cardiotocography shows fetal compromise (repetitive late decelerations, prolonged deceleration, fetal bradycardia) or intrauterine fetal demise. Consumption of clotting factors by the large retroplacental clot frequently leads to disseminated intravascular coagulation (DIC) , evidenced by hypofibrinogenaemia ( < 2.0 g/L < 2.0\text{ g/L} < 2.0 g/L ), prolonged PT/APTT, and elevated D-dimer.

Clinical Comparison: Placenta Praevia vs. Placental Abruption

Vaginal Bleeding : Placenta Praevia: Painless, bright red, recurrent; visible bleeding matches clinical loss; Placental Abruption: Painful, dark red, continuous; may be concealed retroplacentally

Abdominal Pain : Placenta Praevia: Completely absent; Placental Abruption: Severe, constant abdominal and back pain

Uterine Palpation : Placenta Praevia: Soft, relaxed, non-tender, non-irritable; Placental Abruption: Tense, rigid, "woody", exquisitely tender with high resting tone

Fetal Presentation : Placenta Praevia: Commonly abnormal (transverse lie, oblique, high breech); Placental Abruption: Usually normal engagement matching gestational age

Cardiotocography (CTG) : Placenta Praevia: Normal, reassuring fetal heart rate pattern; Placental Abruption: Pathological (late decelerations, severe bradycardia, or absent fetal heart)

Maternal Haemodynamics : Placenta Praevia: Proportional to visible external blood loss; Placental Abruption: Often in hypovolaemic shock out of proportion to visible loss

Coagulopathy (DIC) : Placenta Praevia: Extremely rare; Placental Abruption: Common complication (hypofibrinogenaemia < 2 g/L < 2\text{ g/L} < 2 g/L )

Digital Vaginal Exam : Placenta Praevia: Strictly contraindicated (provokes torrential haemorrhage); Placental Abruption: Strictly contraindicated until ultrasound excludes praevia

Initial Management : Placenta Praevia: TVS confirmation, crossmatch, anti-D, elective C-section; Placental Abruption: Emergent resuscitation, blood/cryoprecipitate, category 1 C-section

Primary references (checked 7 October 2026): Queensland maternity guidelines .